Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial. (Q41654386)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 November 2014

Language	Label	Description	Also known as
English	Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.	scientific article published on 21 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Adrian Streinu-Cercel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Giuseppe Mazzella

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

10

object named as

A Horban

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

M Buti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

W-L Chuang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

F Tabak

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

P Calistru

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Goeser

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Rasenack

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G L Davis

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Alberti

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Pol

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Orsenigo

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Brass

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

21 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

596-606

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25412795%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Current and future therapies for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Hepatitis C in the interferon-free era

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Structural basis for the non-immunosuppressive character of the cyclosporin A analogue Debio 025.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Profile of alisporivir and its potential in the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Statistical considerations for noninferiority/equivalence trials in vaccine development

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Telaprevir for retreatment of HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Perspectives and challenges of interferon-free therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12360

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41654386&oldid=1632130416"